OMGA - Omega Therapeutics GAAP EPS of -$0.54 in-line revenue of $0.48M beats by $0.43M
- Omega Therapeutics press release ( NASDAQ: OMGA ): Q2 GAAP EPS of -$0.54 in-line.
- Revenue of $0.48M beats by $0.43M .
- As of June 30, 2022, the company had cash, cash equivalents and marketable securities totaling $173.7M.
For further details see:
Omega Therapeutics GAAP EPS of -$0.54 in-line, revenue of $0.48M beats by $0.43M